US Patent 11285210 Buffer formulations for enhanced antibody stability
Patent 11285210 was granted and assigned to Outlook Therapeutics, Inc. on March, 2022 by the United States Patent and Trademark Office.
Is a
Date Filed
February 1, 2017
0
Date of Patent
March 29, 2022
0
Patent Applicant
Patent Application Number
16072991
0
Patent Inventor Names
Maria Taddei
0
Hiten Gutka
0
Jessica Cheung
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11285210 Buffer formulations for enhanced antibody stability
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
